These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3437881)

  • 41. [Neuropsychiatric disorders while using hormonal contraceptives (review)].
    Burtsev EM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1391-401. PubMed ID: 6391050
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical detection and assessment of drug induced neurotoxicity.
    Naranjo CA; Fornazzari L; Sellers EM
    Prog Neuropsychopharmacol; 1981; 5(5-6):427-34. PubMed ID: 6280224
    [No Abstract]   [Full Text] [Related]  

  • 43. Dextromethorphan-induced neurologic illness in a patient with negative toxicology findings.
    Cherkes JK; Friedman JH
    Neurology; 2006 Jun; 66(12):1952-3. PubMed ID: 16801672
    [No Abstract]   [Full Text] [Related]  

  • 44. [Role of lead in medicine].
    Goldberg A; Beattie AD
    Recenti Prog Med; 1974 Jun; 56(6):497-519. PubMed ID: 4211635
    [No Abstract]   [Full Text] [Related]  

  • 45. Neuropsychiatric sequelae following chemical exposure.
    Morrow LA; Condray R; Steinhauer SR
    Arch Environ Health; 1995; 50(5):390-1. PubMed ID: 7574896
    [No Abstract]   [Full Text] [Related]  

  • 46. Adverse neurologic effects of glucocorticosteroids.
    Lacomis D; Samuels MA
    J Gen Intern Med; 1991; 6(4):367-77. PubMed ID: 1890511
    [No Abstract]   [Full Text] [Related]  

  • 47. [Undesirable neuropsychological and muscular effects].
    Schelling JL
    Ther Umsch; 1987 Dec; 44(12):968-72. PubMed ID: 3441876
    [No Abstract]   [Full Text] [Related]  

  • 48. Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice.
    Movig KL; Egberts AC; Lenderink AW; Leufkens HG
    J Am Geriatr Soc; 2001 Feb; 49(2):234-5. PubMed ID: 11207885
    [No Abstract]   [Full Text] [Related]  

  • 49. Behavioral toxicology, risk assessment, and chlorinated hydrocarbons.
    Evangelista de Duffard AM; Duffard R
    Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):353-60. PubMed ID: 9182042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Neurological complications of treatments with vincristine. Clinical study of 100 patients treated with vincristine].
    Goldstein B; Lhuillier M
    Ann Med Interne (Paris); 1974; 125(6-7):571-6. PubMed ID: 4374109
    [No Abstract]   [Full Text] [Related]  

  • 51. [Isolated neuropsychiatric manifestations related to a digoxin overdose. Apropos of a case].
    Moreau D; Turner L; Dupont C; Deschiens MA; Rouveix E; Dorra M
    Ann Med Interne (Paris); 1997; 148(1):108-9. PubMed ID: 9137706
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of organic solvents.
    Waldron HA
    Br J Hosp Med; 1981 Dec; 26(6):645-9. PubMed ID: 7034837
    [No Abstract]   [Full Text] [Related]  

  • 53. Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir.
    Lê MP; Gervais A; Le Beller C; Long K; Larrouy L; Papy E; Mal H; Descamps D; Peytavin G
    J Antimicrob Chemother; 2013 May; 68(5):1208-9. PubMed ID: 23335198
    [No Abstract]   [Full Text] [Related]  

  • 54. Toxicity to the nervous system of diphenylhydantoin: a review.
    Ziegler DK
    Int J Neurol; 1978; 11(4):383-400. PubMed ID: 94596
    [No Abstract]   [Full Text] [Related]  

  • 55. Severe nervous system complications after botulinum type A therapy: three case reports with reviews of FDA-reported nervous system adverse effects.
    Hristova AH; Joseph LN; Sathe SA; Wade JB
    PM R; 2012 Aug; 4(8):613-23. PubMed ID: 22920316
    [No Abstract]   [Full Text] [Related]  

  • 56. Psychotropic drugs--neurotoxicity.
    Zaratzian VL
    Clin Toxicol; 1980 Sep; 17(2):231-70. PubMed ID: 6998646
    [No Abstract]   [Full Text] [Related]  

  • 57. FDA requires warnings on anti-malaria drug Lariam.
    Consum Rep; 2004 Jan; 69(1):45. PubMed ID: 14677548
    [No Abstract]   [Full Text] [Related]  

  • 58. Levodopa.
    JAMA; 1970 Dec; 214(11):2059-60. PubMed ID: 5536484
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapy of nervous system intoxications].
    Greif S
    Bibl Psychiatr Neurol; 1969; 139():206-32. PubMed ID: 4400240
    [No Abstract]   [Full Text] [Related]  

  • 60. The IPCS collaborative study on neurobehavioral screening methods.
    Moser VC; Becking GC; MacPhail RC; Kulig BM
    Fundam Appl Toxicol; 1997 Feb; 35(2):143-51. PubMed ID: 9038235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.